Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs

机译：早期转化为持续糖尿病黄斑水肿的AfliBercept导致更好的视觉结果和较低的治疗费用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Clinical Ophthalmology (Auckland N.Z.)
作者
David J Ramsey; Samuel J Poulin; Lauren C LaMonica; Gregory R Blaha; Fina C Barouch; Jeffrey Chang; Jeffrey L Marx;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类眼科学;
关键词
diabetic macular edema; DME; socioeconomics; diabetic retinopathy;

机译：糖尿病黄斑水肿;DME;社会经济;糖尿病视网膜病变;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective [J] . Stephane A Régnier, William Malcolm, Jennifer Haig, ClinicoEconomics and Outcomes Research . 2015,第2期

机译：雷尼单抗与阿柏西普治疗糖尿病性黄斑水肿所致视力障碍的成本效益：英国医疗保健观点
2. Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab [J] . Donald R Nixon, Nicholas AP Flinn Clinical ophthalmology . 2018,第9期

机译：糖尿病性黄斑水肿患者接受兰尼单抗治疗后改用阿非西普治疗后的对比敏感性和其他视觉功能评估
3. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema: One Year Follow Up [J] . Aderman Christopher M., Rahimy Ehsan, Shahlaee Abtin, Investigative ophthalmology & visual science . 2017,第8期

机译：对持续糖尿病患者水肿的先前抗VEGF治疗后转化为AFLIBERCEPT：一年的跟进
4. Morphology of vascular network in eyes with diabetic macular edema varies based on tolerance of aflibercept treatment interval length: preliminary findings [C] . Prateek Prasanna, Justis Ehlers, Nathaniel Braman, Biomedical Applications in Molecular, Structural, and Functional Imaging . 2019

机译：患有糖尿病黄斑水肿的眼睛中血管网络的形态基于AfliBercept治疗间隔长度的耐受性因耐受性而变化：初步调查结果
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective [O] . Stephane A Régnier, William Malcolm, Jennifer Haig, 2015

机译：雷尼单抗与阿柏西普治疗糖尿病性黄斑水肿所致视力障碍的成本效益：英国医疗保健观点
7. Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs [O] . David Ramsey, Samuel J Poulin, Lauren C LaMonica, 2021

机译：早期转化为持续糖尿病黄斑水肿的AfliBercept导致更好的视觉结果和较低的治疗费用

Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs

著录项

相似文献

相关主题

期刊订阅